Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bleeding Active”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT05391607
What this trial is testing

Comparison Between Hyperoncotic and Isooncotic Albumin to Support Blood Loss Replacement

Who this might be right for
Blood Loss, SurgicalFluid Retention
Insel Gruppe AG, University Hospital Bern 42
Very early researchUnknownNCT00526500
What this trial is testing

Effect of Passive Gait Training on the Cortical Activity in Patients With Severe Brain Injury.

Who this might be right for
Craniocerebral TraumaTraumatic Brain InjurySubarachnoid Hemorrhage+1 more
University of Aarhus 60
Large-scale testing (Phase 3)Study completedNCT03461406
What this trial is testing

Safety and Efficacy of Fibrin Sealant Grifols as an Adjunct to Haemostasis During Surgery in Paediatric Participants

Who this might be right for
Excessive Bleeding During Surgery
Instituto Grifols, S.A. 186
Testing effectiveness (Phase 2)Study completedNCT00888940
What this trial is testing

Outcomes and Safety Trial Investigating Ecallantide's Effect on Reducing Surgical Blood Loss Volume in Subjects at High Risk of Bleeding Exposed to Cardio-pulmonary Bypass During Cardiac Surgery

Who this might be right for
BloodlossSurgical Procedures, Operative
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 243
Not applicableLooking for participantsNCT07620184
What this trial is testing

Swedish National Parotidectomy Study (SNaPs): Drainless Versus Standard Surgery

Who this might be right for
Parotid NeoplasmsPost-operative ComplicationsSeroma as Procedural Complication
Uppsala University Hospital 600
Post-approval studies (Phase 4)Study completedNCT00745901
What this trial is testing

Study to Evaluate Cycle Control With Norgestimate/Ethinyl Estradiol and Drospirenone/Ethinyl Estradiol in Healthy Sexually Active Females

Who this might be right for
Contraception
Ortho-McNeil Janssen Scientific Affairs, LLC 355
Not applicableNot Yet RecruitingNCT07824739
What this trial is testing

AI Assistance for Detecting Active Bleeding During DSA Procedures

Who this might be right for
DSABleedingAI (Artificial Intelligence)+2 more
Zhongda Hospital 1,324
Not applicableStudy completedNCT03112525
What this trial is testing

DAPHNE Study: Direct Anticoagulant PHarmacogeNEtic

Who this might be right for
Anticoagulants and Bleeding Disorders
University Hospital, Geneva 300
Not applicableStudy completedNCT01830712
What this trial is testing

A Long-term Assessment of Physical Activity, Range of Motion, and Functional Status Following Elective Orthopedic Surgery in Hemophilia Patients With Inhibitors

Who this might be right for
Congenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors
Novo Nordisk A/S 15
Not applicableNot Yet RecruitingNCT06415422
What this trial is testing

Platelet Activity Monitoring for Patients Under Adp Medication Using Verify Now in Subdural Hematoma

Who this might be right for
Hematoma, Subdural
University Hospital, Brest 40
Testing effectiveness (Phase 2)Looking for participantsNCT07127042
What this trial is testing

Study on BT-114143 Reducing Perioperative Bleeding in Total Knee Arthroplasty（TKA）

Who this might be right for
Total Knee Arthroplasty
ScinnoHub Pharmaceutical Co., Ltd. 270
Not applicableUnknownNCT02214524
What this trial is testing

Comparison of Active and Passive Perioperative Warming Techniques in Reducing Intraoperative Blood Loss

Who this might be right for
HypothermiaBlood Loss,Blood Coagulation Disorders
Peking Union Medical College Hospital 60
Testing effectiveness (Phase 2)Study completedNCT03395210
What this trial is testing

Rilzabrutinib in Adult Patients With Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia
Principia Biopharma, a Sanofi Company 86
Not applicableUnknownNCT04612881
What this trial is testing

Fitostimoline Vaginal Pessaries in Women With Hysterectomy. Randomized, Perspective, Monoscentric Study.

Who this might be right for
Vaginal Bleeding
University of Milan 60
Large-scale testing (Phase 3)UnknownNCT00370721
What this trial is testing

Intravitreal Bevacizumab for Management of Active Progressive Proliferative Diabetic Retinopathy (PDR)

Who this might be right for
Diabetic Retinopathy
Shahid Beheshti University of Medical Sciences
Post-approval studies (Phase 4)Looking for participantsNCT03675672
What this trial is testing

Prevention of Recurrent Ulcer Bleeding in Patients With Idiopathic Gastroduodenal Ulcer

Who this might be right for
Active Peptic Ulcer Disease/GI Bleeding
Chinese University of Hong Kong 154
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07459114
What this trial is testing

TGD001 Treatment in Thrombotic Microangiopathies

Who this might be right for
Thrombotic MicroangiopathiesITP Immune-Mediated Thrombocytopenia
TargED Biopharmaceuticals B.V. 70
Testing effectiveness (Phase 2)UnknownNCT04114643
What this trial is testing

Factor Replacement in Surgery

Who this might be right for
Bleeding in Cardiac Surgery
University Health Network, Toronto 103
Large-scale testing (Phase 3)Study completedNCT02141074
What this trial is testing

Safety and Efficacy of Nonacog Beta Pegol (N9-GP) in Previously Untreated Patients With Haemophilia B

Who this might be right for
Congenital Bleeding DisorderHaemophilia B
Novo Nordisk A/S 54
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07019545
What this trial is testing

A PHASE II TRIAL AIMING TO INVESTIGATE THE SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN IN ADULT PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA PREVIOUSLY TREATED WITH A THROMBOPOIETIN RECEPTOR AGONIST AND/OR RITUXIMAB AFTER CORTICOSTEROID FIRST-LINE THERAPY

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Hellenic Society of Hematology 14
Next Page